In this study, the low molecular weight lypophilic metabolites of C.albicans and C. dubliniensis strains produced in a synthetic medium with the addition of fetal calf serum were identified using LC/MS and MS/MS technique and quantified. All strains investigated produce a metabolite with a UV spectra maximum at 224 and 279 nm and minimum at 243 nm. Following comparison with ESI, MS/MS spectral data of a reference compound, the metabolite was identified as 3-indoleethanol (tryptophol). The concentration of extracellular tryptophol in the biosynthesis of C. albicans and C. dubliniensis ranged from 2.45 µg/mL to 191 µg/mL, respectively. Contrary to previously published data, gliotoxin or gliotoxin-like compounds were not detected, and all investigated C. albicans and C. dubliniensis strains have the same metabolite profile. Cytotoxic effects of tryptophol and 3-indolelactic acid (precursor of tryptophol biosynthesis) were cell-line-dependent. The EC 50 of tryptophol ranged between 2 and 7 mM, with the EC 50 of 3-indolelactic acid approximately double (between 4 and 8 mM). Tryptophol exhibited cell-type dependent cytotoxicity in relatively high concentrations, with domination of apoptosis.
ABSTRACT
In this study, the low molecular weight lypophilic metabolites of C.albicans and C. dubliniensis strains produced in a synthetic medium with the addition of fetal calf serum were identified using LC/MS and MS/MS technique and quantified. All strains investigated produce a metabolite with a UV spectra maximum at 224 and 279 nm and minimum at 243 nm. Following comparison with ESI, MS/MS spectral data of a reference compound, the metabolite was identified as 3-indoleethanol (tryptophol). The concentration of extracellular tryptophol in the biosynthesis of C. albicans and C. dubliniensis ranged from 2.45 µg/mL to 191 µg/mL, respectively. Contrary to previously published data, gliotoxin or gliotoxin-like compounds were not detected, and all investigated C. albicans and C. dubliniensis strains have the same metabolite profile. Cytotoxic effects of tryptophol and 3-indolelactic acid (precursor of tryptophol biosynthesis) were cell-line-dependent. The EC 50 of tryptophol ranged between 2 and 7 mM, with the EC 50 of 3-indolelactic acid approximately double (between 4 and 8 mM). Tryptophol exhibited cell-type dependent cytotoxicity in relatively high concentrations, with domination of apoptosis.
INTRODUCTION
Candida species are yeasts that exist as a commensal microflora of human and animals. They colonize the mucosal surfaces of the oral and vaginal cavities, the intestines and can be found on skin (1, 2) . Opportunistic mycoses caused by Candida spp. are infrequent in immunocompetent individuals, where yeasts mainly cause superficial mycoses such as vulvovaginal and oropharingeal candidiasis or chronic mucocutaneous candidiasis. Changes in the host are generally required for opportunistic pathogens to change from harmless commensals to invasive pathogens (3) . The factors affecting opportunistic candidosis include: use of antibiotics, steroids and chemotherapy, lymphoma or hematologic malignancy, allogeneic transplantation, HIV-infection and iatrogenic immunosuppression (4) . Candida infections have increased dramatically over the past three decades in patients undergoing immunosuppressive antineoplastic therapy or therapy associated with organ transplantation, cancer-patients, long-term catheterization, and use of broad-spectrum antibiotics, mainly in the population of immunocompromised patients (5) (6) (7) (8) .
Among the species of the genus Candida, polymorphic C. albicans is generally the most common species, causing mycoses above a range of other species including C. tropicalis, C. glabrata, C. krusei, C. kefyr, C. parapsilosis, C. guillermondii, C. famata, C. dubliniensis, etc. (8, 9) .
The switch from harmless commensalisms into an invasive pathogenic state of Candida spp. depends mainly on the nature of the underlying host defect. With the exception of host factors, several virulence factors have been attributed to Candida spp. which contribute to change from commensalism to disease. Virulence attributes of Candida spp. include adhesion, as the first and essential step in the establishment of disease. Candida blastospores can also adhere to surfaces of medical devices and form biofilms, which results in an increase of candidemia and antifungal resistance related to catheter insertion (10) (11) (12) . Polymorphism, as the ability to undergo reversible morphogenetic transitions between yeast, pseudohyphae, and hyphae and a feature unique to C. albicans and C. dubliniensis species among all the Candida spp., has been shown to be important for its pathogenicity in systemic infections (13) (14) (15) (16) . Secretion of extracellular hydrolytic enzymes such as aspartyl proteinases (17) (18) (19) , phospholipases (20), lipases (21) and hemolysins (22) (23) (24) (25) were described as virulence factors of Candida species. These factors likely contribute to pathogenicity, as some enzymes degrade proteins at lesion sites (such as albumin, hemoglobin, keratin, IgA, etc.) (33) . Colonies of C. albicans can switch among different phenotypes, though the mechanism of switching and the involvement of this switching and virulence remains unclear (26) (27) (28) .
The production of low-molecular-weight (LMW) metabolites of secondary fungal metabolism (mycotoxins) among certain filamentous fungi and its toxicity on mammals has been described, and the production of some toxic LMW during mycoses has been demonstrated (29) (30) .
In the group of medically important yeasts of Candida species, the production of LMW metabolites and its toxic role on host cells have been poorly studied, and therefore this study addresses the production of LMW metabolites and its cytotoxic activity on different cell lines in vitro.
MATERIALS AND METHODS

Source of Candida albicans and C. dubliniensis strains and species identification
A total of 64 strains of Candida albicans and 6 strains of C. dubliniensis were analyzed for the presence of LMW metabolites. Half the C. albicans strains examined were clinical isolates collected from patients with vaginitis, urinary tract infections, or respiratory tract infections. Commensal isolates of C. albicans strains were isolated from the mouth or stool specimens of healthy donors undergoing regular examinations in the Zagreb Public Health Institute. C. dubliniensis strains were donated by Prof. Derek Sullivan (Trinity College, Dublin).
The yeasts were identified as follows: Candida albicans were identified using phenotypic characteristics on Sabouraud 2% (w/V) -glucose agar (Fluka, Germany), chlamydospore formation on rice-polisorbate 80 agar (Fluka, Germany), and "germ-tube" formation in fresh human serum (Fluka, Germany) according to Larone (31) . All yeasts presumptively identified as C. albicans were plated on Pal's-agar (sunflower-seed agar) according to method described by Al Mosaid et al. (32) and incubated for 72h at 25±2°C, and on Sabouraud 2% (w/V)-glucose agar for 18h at 45±1°C for possible misidentified C. dubliniensis strains. Identification of C. albicans was also confirmed using Candida ID agar (bioMérieux, France) and Api Candida (bioMérieux, France).
In vitro biosynthesis and extraction of lowmolecular-weight (LMW) metabolites
Prior to analysis, all strains of C. albicans and C. dubliniensis were maintained on potato-dextrose agar (Fluka, Germany), and then incubated for 24h at 37°C. After incubation, the inoculum was prepared by sampling 10 yeast colonies with a loop, which was then transferred to 5 mL sterile physiological solution. The inoculum was vortexed, and 1 mL was transferred to plastic Roux flasks (250 mL) with 100 mL of sterile minimal essential medium Eagle (MEM, Sigma, Germany) with 5% (V/V) fetal calf serum (Sigma, Germany). C. albicans and C. dubliniensis strains were incubated for six days at 37°C, in two groups: one in an incubator under normal atmospheric conditions and the other in an humified incubator with 5% CO 2 .
At the end of the incubation period, the LMW metabolites from biosynthesis were extracted with 70 mL chloroform (Fischer Scientific, USA). The mixture was centrifuged for 30 minutes at 5200 rpm, and the chloroform fraction was evaporated in a vacuum at 50°C. The dry extract was dissolved in 200 µL methanol (Fischer Scientific, USA), filtrated through a 0.45 µm filter, and 20 µL was injected into a chromatographic column.
For the LMW-metabolites production kinetics, C. albicans MFBF* 40 (isolated from clinically manifested vulvovaginitis) was inoculated in MEM at 37ºC and the production of LMW metabolites was quantified every 18 hours (over 7 days) following extraction of biosynthesis. Production kinetics was conducted in triplicate, and mean ± standard deviation of LMW metabolites was calculated. 
HPLC-DAD analysis
Lipophylic LMW metabolites analysis was performed by high pressure liquid chromatography with diode-array detection (Kontron Instruments, Milan, Italy) and a 150 mm x 4 mm Zorbax ODS 5 µm C 18 column (Bischoff, Germany). HPLC analysis was performed with a linear elution gradient by using 0.2% (V/V) acetic acid (Fischer Scientific, USA) (solvent A) and acetonitrile (Fischer Scientific, USA) (solvent B) according to the method described by Frisvad (33) . The flow rate was set to 2 mL min -1 .
Mass spectrometry analysis
The HPLC-MS-MS instrument used was a LCQ DUO Ion Trap coupled with a HPLC system from ThermoFinnigan (San Jose, CA, USA). HPLC was performed on a reverse phase column 150 × 2.1 mm Kromasil 5C 18 column. Twenty µL of the methanol solution was injected directly into the HPLC system. Gradient chromatography (run of 33 min) was performed with 10 mM ammonium acetate in water (eluent A)-methanol (eluent B) as the mobile phases at a flow rate of 0.2 mL min -1 . The program initiates with 90/10 eluent A/B for 3 min, then eluent B was increased to 90% within 22 min, then held constant for 5 minutes, and finally returned to 90/10 eluent A/B for 3 min and allowed to re-equilibrate for 5 min. HPLC-MS measurements were performed using the electrospray ionization mode (ESI). ESI was performed at room temperature in a negative mode; tension was maintained at 4.5 kV with a capillary temperature of 250°C. MS and MS-MS adjustments were made with tryptophol. The collision energy was set at 35%.
Chemical standards and quantification by HPLC
Tryptophol (3-indoleethanol), DL-3-indolelactic acid and gliotoxin were purchased from Aldrich (Germany) and DL-tryptophan were purchased from Fluka (Germany). Before HPLC analysis, standards were dissolved in methanol to a final concentration 10 µg/mL and filtersterilized through a 0.45 µm pore-size filter. Quantification of tryptophol produced in biosynthesis was performed with a one-fifth concentration mixture of tryptophol standard in methanol (from 1 mg/mL to 0.1 µg/mL), and the peak area vs. concentration at 270 nm was calculated. The concentration curve (R 2 >0.99) was used for calculation of tryptophol.
CYTOTOXICITY SCREENING
Cell lines and culture conditions
The five different cell lines used in the cytotoxicity assay were purchased from the European collection of cell lines -ECACC (strain number in brackets): human monocyte leukemia THP 1 (ECACC 88081201), human Caucasian hepatocyte carcinoma (epithelial) Hep G2 (ECACC 86012804), Chinese hamster ovary (epithelial) CHO (ECACC-85050302), human Caucasian lung carcinoma (epithelial) A549 (ECACC 88081201) and fibroblasts of African green monkey COS-7 (ECACC 87021302). All cells were maintained in Dulbecco's modified Eagle's Medium (Sigma, Germany) with 10% (V/V) of fetal calf serum (Sigma, Aldrich), penicillin (100 U/mL), streptomycin (100 µg/mL), and amphotericin B (0.25 µg/mL) at 37ºC and humified with 5% CO 2 , after removing cells from liquid nitrogen stock.
The MTT cytotoxicity assay
Compounds were examined for antiproliferative or cytotoxic continuous drug exposure by the CellTiter 96 ® Non-Radioactive Cell Proliferation Assay (Promega, USA), which is a non-radioactive colorimetric assay for measuring the number of viable cells in proliferation and cytotoxicity assays. Both adherent and suspension cells may be analyzed with this system. Compounds were dissolved in DMSO, and added to the microtiter plate wells in final concentrations: 20, 10, 5, 2.5, 1.25, 0.63, 0.31 and 0.16 mM (tryptophol and 3-indolelactic acid), or 50, 25, 12.5, 6.25, 3.13, 1.56, 0.78 and 0.39 µM (gliotoxin). Final dilution of DMSO did not exceed 1%. Test was performed on a defined set of different cell lines and each well contained from 50000 to 75000 (in the case of THP-1) cells. Cultures exposed to compounds, or 10% DMSO as a control, were incubated for 24 h. After exposure time, a 15 µL of the Dye Solution, containing the tetrazolium salt MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide), was added directly to the cells and is internalized and reduced into an insoluble formazan product by cellular metabolism (succinate dehydrogenase mitochondrial activity). Only those cells which are living at the time the dye is added will significantly reduce the MTT. The Solubilization Solution is added to lyse the cells and dissolve the formazan dye product. After 1-4 incubation hours, samples are read in a spectrophotometric 96-well plate reader (Ultra, TECAN, USA) at 490 nm (34) . The intensity of the color that appears is directly proportional to the number of viable cells. Method was programmed for TECAN robotic system in GEMINI pipetting software (TECAN, USA), and the results were expressed as percentage of OD values of non-treated cells and as IC 50 values
Assessment of cell viability, apoptosis and necrosis in human lymphocyte ex situ
Blood sampling
A blood sample was obtained from a healthy male donor (age 35 years, non-smoker) who gave his informed consent for participation in the study. The donor had not been exposed to diagnostic or therapeutic irradiations or to known genotoxic chemicals for a year before blood sampling. Venous blood (20 ml) was collected under sterile conditions in heparinised vacutainer tubes (Becton Dickinson) containing lithium heparin (Sigma, Germany) as an anticoagulant.
Test chemical
Tryptophol was dissolved in ethanol (40% water solution) to a final concentration of 64 mg/mL. The concentrations tested in the in vitro experiment corresponded to 2.00 mM, 1.00 mM, 0.50 mM and 0.25 mM.
Experimental procedure
Two independent experiments were performed for each concentration tested. Aliquots of freshly drawn venous blood were placed in sterile Falcon tubes and mixed with RPMI-1640 culture medium (Gibco, USA). They were incubated in vitro for 24h at 37°C in an humified atmosphere with 5% CO 2 . Tryptophol was added to achieve final concentrations of 2.00 mM, 1.00 mM, 0.50 mM and 0.25 mM. The solvent (40% ethanol) and negative controls were incubated in parallel. Following treatment, the culture 
4.3.4.. Lymphocyte isolation
Lymphocytes were isolated using a modification of the Ficoll-histopaque centrifugation method (35) . Samples mixed with RPMI medium (1 mL) were placed in a 2.0 mL microfuge tube. Then, 500 µL of cold lymphocyte separation medium (Sigma) was layered at the bottom of the tube using a pipetman, and RPMI 1640 was added up to 2 mL. The sample was centrifuged at 4500 rpm for 3 min in a microfuge at room temperature. The lymphocytes in the upper part of the ficoll layer were pipetted out. Cells were washed twice in 0.5 mL of RPMI-1640, using centrifugation for 3 min at 4500 rpm in the microfuge. The final pellet was gently resuspended in RPMI-1640 and used in the assessment of cell viability.
Assessment of cell viability, apoptosis and necrosis
The dye exclusion method (36) was applied to study cell death and morphological changes in the nuclei, in which viable (intact plasma membrane) and dead (damaged plasma membrane) cells can be visualized after staining with fluorescent DNA-binding dyes (Figure 1 ). Ethidium bromide (Sigma, Germany) and acridine orange (Sigma, Germany) were added to the cell suspension in final concentrations of 100 µg/mL (1:1; V/V). Two parallel tests with aliquots of the same sample were performed and a total of 400 cells per sample were counted. Quantitative assessments were made by determination of the percentage of apoptotic and necrotic cells.
Statistical analysis
All statistical analyses were performed using GraphPad Prism Software (Sand Diego, CA, USA). The ttest was used to compare differences in tryptophol production between strains and between species, as well as between concentrations of tryptophol obtained after incubation under 5% CO 2 and under normal atmospheric conditions. For viability assessments, the χ 2 test was used to compare values obtained for cell viability, apoptosis and necrosis in tryptophol-treated and control samples. Differences were considered significant at p < 0.05.
RESULTS AND DISCUSSION
Production of LMW metabolites of C. albicans and C. dubliniensis
The representative HPLC chromatogram of C. albicans (N=64) and C. dubliniensis (N=6) strains are presented in Figure 2a . Following six days of incubation, only one compound was isolated from all the investigated strains, and peak with retention time was found around 15 minutes. The UV spectra showed maximums at 224 and 279 (Figure 2b ). This UV spectrum displayed a strong similarity with the characteristic UV spectrum of indolelike compounds. Using tryptophan, 3-indoleelthanol (tryptophol), 3-indoleacetic acid, and gliotoxin, only tryptophol showed a similar retention time and UV spectrum with those of the compound isolated in C. albicans and C. dubliniensis strains culture extract. As only one compound was isolated from the biosynthesis of all 64 strains of C. albicans and 6 strains of C. dubliniensis, further identification using MS and MS/MS in the negative ESI mode were performed. The fraction with a retention time between 14.5 and 15 mm was collected using HPLC-DAD and analyzed with LC-MS. The LC-MS chromatogram displayed a unique major peak with a base peak at m/z 160 (Figure 2c) . Analysis of the fraction by direct injection mass spectrometry allowed MS/MS data to be obtained (Figure 2d ). These data matched the tryptophol standard MS (Figure 2e ) and MS/MS spectrum (Figure 2f It is not surprising that tryptophol, as a lowmolecular-weight lypophilic alcohol, was found in the biosynthesis of polymorphic C. albicans and C. dubliniesis strains in synthetic media such as Eagle's minimal essential medium (MEM). An earlier study by Ligappa et al. (38) performed isolation and identification of the metabolites tryptophol, 2-phenylethanol and dimer of cyclo(prolineleucine) by means of infrared and mass spectra from chloroformic extracts from the biosynthesis of C. albicans in Sabouraud sucrose broth. Tryptophol and 3-indolelactic acid were also isolated from the biosynthesis of C. albicans Z248, C. guillermondii Z55, C. krusei Z70 and C. tropicalis Z56 (39) in L-tryptophan (0.25% m/V) rich medium. In a later study, various amounts of tryptophan were converted into tryptophol and 3-indolelactic acid, in concentration depending on Candida species. However, the present study, using different C. albicans and C. dubliniensis strains (from respiratory and uro-genital tracts, as well as commensal isolates and isolates from clinically manifested mycoses), found tryptophol as the only low-molecular weight metabolite. Similar to the findings of Narayanan and Rao (39), a previous study (40) showed that C. guillermondi, C. kefyr, C. krusei, C. parapsilosis, C. tropicalis were found as lower tryptophol-producing species, while the production of tryptophol in the biosynthesis of C. famata and C. glabrata was not detected. C. tropicalis was found to be a low-producer of tryptophol (1.63±0.49 µg/mL), followed by C. parapsilosis (13.05±6.48 µg/mL), C. krusei (13.64±4.92 µg/mL), C. kefyr (18.34±5.11 µg/mL) and C. guillermondii (22.83±4.70 µg/mL), respectively (40). yield tryptophol as the end product, with 3-indolepyruvate and 3-indoleacetaldehyde as intermediary products. S. cerevisiae secretes phenylethanol (as the end-product of catabolism of phenylalanine) and tryptophol and they stimulate diploid pseudohyphal growth of S. cerevisiae (42) . Interestingly, Chen and Fink (43) found that low concentrations of either phenylethanol or tryptophol stimulated filamentous growth of S. cerevisiae, and they acted synergistically. However, another aromatic alcoholtyrosol (as the end-product of catabolism of tyrosine) did not stimulate pseudohyphal growth of S. cerevisiae, which indicates the structure-relationship activity of these alcohols (44) . Interestingly, in a culture of C. albicans cells, tyrosol accelerates the morphological conversion of C. albicans-yeastform cells to filaments (45) . Another substance isolated from the culture of C. albicans acting as an autoregulatory molecule is farnesol which, contrary to tryptophol and tyrosol, suppress germ-tube formation of C. albicans cells (45, 46) . However, the nature of dimorphic behavior of C. albicans cells depend not only on the presence and concentration of autoregulatory substances such as tyrosol, tryptophol and farnesol, but also on different factors, including the presence of various chemical and environmental parameters such as temperature, pH, glucose levels, nitrogen source, CO 2 levels, transition metals, chelating agents, inoculum size, and initial cell density (47, 48) . The very important role of alcohols in biofilmdevelopment has been connected with tyrosol and farnesol (48) . Cells of C. albicans in biofilm secrete approximately 50% more tyrosol than did planctonic cells, and this action on biofilm formation is most significant during the early and intermediate stage of biofilm formation (48) .
The present findings showed that tryptophol (3-indoleethanol), as the end-product of tryptophan catabolism, was the only low-weight-molecular metabolite in the biosynthesis of polymorphic C. albicans and C. dubliniensis strains in MEM with the addition of 5% (V/V) fetal calf serum. In this media, tryptophol was found to be only metabolite, though its production was not significantly different between filamentous polymorphic C. albicans and C. dubliniensis strains (Figure 3a) .
However, earlier studies performed by Shah and Larsen (49) and Shah (50) suggested that clinical isolates of C. albicans strains secrete the potent immunosuppressive mycotoxin gliotoxin (from the class of epipoythiodioxopiperazine secondary metabolites) after seven days in synthetic media with 5% fetal calf serum. Gliotoxin was found in clinical C. albicans isolates from women with vulvovaganitis with a frequency of 32 gliotoxin-positive strains of 50 tested by Shah and Larsen (49) . Furthermore, Shah et al. (51) found gliotoxin production in vaginal samples of three women with clinically manifested candidosis, while women without vaginal colonization by C. albicans were found to be gliotoxin-negative. After the findings of Shah et al. (49) (50) (51) , gliotoxin was cited in articles and reviews as one of the virulence factors of C. albicans.
Our findings clearly show that C. albicans (both commensal and clinical isolates) and C. dubliniensis strains do not produce the immunosuppressive mycotoxin gliotoxin, which was also described by Kupfal et al. (52) . Similar to Kupfal et al. (52) we did not find gliotoxinproducing Candida species between clinical and commensal isolates of C. parapsilosis, C. kefyr, C. krusei, C. glabrata, C. tropicalis. C. guillermondii and C. famata (53, 54) .
Discrepancies can even be found in the numbers of strains between two species. Production of tryptophol was similar between strains of C. albicans and C. dubliniensis species ( Table 1 ). The concentration of tryptophol was 49.10±34.99 µg/mL between strains of C. albicans, and 72.81±52.31 µg/mL between strains of C. dubliniensis, respectively, without significant differences in production (p>0.05). Tryptophol production between strains of both Candida species was in the high range, with a minimum at 2.45 µg/mL and maximum at 191 µg/mL. When tryptophol production was compared between C. albicans isolates regarding body site of isolation, no significant differences were found (Figure 3b) . Similar results in tryptophol production have been noted between isolates of C. albicans strains isolated from clinically manifested candidosis and from mouth and stool specimens of donors without manifestation of mycoses (commensal isolates). The results are presented in Figure 3c .
Environmental conditions such as temperature and CO 2 are known to trigger the switch from yeast-like cells to the filamentous invasive form of C. albicans (1). Therefore we checked the influence of 5% CO 2 on tryptophol production which, together with serum in Eagle's minimal essential medium C. albicans, were in the filamentous form. Surprisingly, tryptophol production was found to be significantly lower in a 5% CO 2 atmosphere (Figure 3d ). As presented in Figure 8 , both Candida species produce more tryptophol under normal atmospheric conditions than under 5% CO 2 .
Using production kinetics, measurable amounts of tryptophol were produced in the biosynthesis of C. albicans MFBF 40 after 18 hours, with an increase of tryptophol production during 162 hours (Figure 4a ). Contrary to the findings of Narayanan and Rao (39), 3-indolelactic acid was not isolated from the biosynthesis of C. albicans MFBF 40 during the incubation period.
There is no data about the in vivo production of any of low-molecular-weight metabolites produced by Candida spp. It could be hypothesized that during candidosis, filamentous C. albicans and C. dubliniensis can secrete tryptophol extracellulary in the environment. The possible role of this metabolite upon host cells and/or commesal bacteria is unknown. Interestingly, tryptophol is a tryptophan metabolite of the blood flagellate parasite African trypanosomes (Trypanosoma brucei), which produces tryptophol in vitro. Tryptophol is established as a hypnotic agent participating in pathophysiological mechanisms provoking a sleep-like or comatose state known as trypanosomal sleeping sickness (55) (56) (57) (58) . Moreover, when tryptophol was injected into laboratory mammals and chicks, it induced a sleep-like state and lethargy accompanied with alteration of body temperature (57, 59) .
In humans, tryptophol is a minor product of tryptophan metabolism. However, its production in the Table 2 . Cytotoxicity induced by tryptophol and its precursor 3-indolelactic acid
The effective concentration (EC 50 ) values of tryptophol and 3-indolelactic acid following 24h exposure measured by the MTT assay using A549, Hep G-2, THP-1, COS-7 and CHO cell lines. Gliotoxin was used as control liver significantly increased with alcohol consumption and following disulfiram treatment (57, 60) . Ethanol-induced modification of the metabolism of biogenic indole amines also results in the increased production of tryptophol compounds (61) . Tryptophol is a highly lypophilic compound that freely penetrates cell membranes (61) . Due to the irreversible alterations of water permeability, it induces erythrocyte lysis (62) . When administered to laboratory animals, it was rapidly distributed to the brain and other tissues. Tryptophol also readily penetrates into lymphoid tissues and its immunosuppressive effects have been observed in mice (63) . Despite interesting biological effects, the overall toxicity profile of tryptophol has not yet been adequately explained. Recent studies concerning mutagenicity of tryptophol using the Ames test on Salmonella enterica serovar Typhymurium TA98 and TA100 tester strains without metabolic activation and with the S9 fraction showed no mutagenic effect in doses up to 1.6 mg/plate (64) . The newest reports on tryptophol toxicity by Inagaki et al. (65, 66) indicate its capability to induce apoptosis in human monoblastic leukemia U937 cells, while lymphocytes were less affected by tryptophol.
Cytotoxicity screening on different cell lines and lymphocyte viability
The cytotoxicity of tryptophol, as well as its precursor 3-indolelactic acid from tryptophan catabolism, is presented in Figures 4b and 4c . Gliotoxin, known as cytotoxic mycotoxin in µM concentrations (68) (69) (70) , was used as a control (Figure 4d ).
Tryptophol treatment for 24 h caused cell viability to decrease in a dose-dependent manner, with effective concentrations depending on cell type. THP-1, A549 and Hep G-2 cell types were found to be the most sensitive to the cytotoxic effect of tryptophol with an EC 50 of 2 and 3 mM, respectively (Table 2) . COS-7 and CHO were most resistant, with an EC 50 of tryptophol of 6 and 7 mM, respectively (Table 2) . Gliotoxin expresses strong cytotoxic activity in cultures of all cell types tested with EC 50 below or equal to 11 µM, which are approximately 1000 x lower concentrations than tryptophol.
3-indolelactic acid was found to be less cytotoxic than tryptophol, with an EC 50 in double concentration for A549 and THP-1 cell types. A possible explanation of the lower cytotoxic potential of 3-indolelactic acid is carboxyl moiety in the molecule, instead of ethyl in the tryptophol molecule.
Lymphocyte viability in the control sample after 24 h of in vitro incubation was 89%. The percentages of viable and non-viable apoptotic or necrotic lymphocytes after 24-h in vitro exposure to tryptophol are shown in Figure 4e . In vitro treatment with tryptophol caused a dosedependent decrease in cell viability, accompanied by increases in the percentage of apoptotic and necrotic cells. It was observed that apoptosis dominated over necrosis in all samples analyzed. Significantly reduced cell viability compared to the control was observed at each dose of tryptophol (p<0.05, χ 2 test) while the solvent did not significantly reduce cell viability. Inter-group comparisons showed that differences in cell viability between samples treated with 0.25 mM and 0.50 mM, as well as between samples treated with 1.00 mM and 2.00 mM were not statistically significant (p>0.05, χ 2 test).
Based on the results obtained in the present study, apoptosis was primary mode of lymphocyte death following in vitro treatment with a dose range 0.25 to 2.00 mM. Tryptophol was also recently established as an effective inducer of apoptosis. Inagaki et al. (66) reported the ability of tryptophol isolated from black soybean vinegar to induce apoptosis in U937 cells (human monoblastic leukemia), but not in normal lymphocytes that were studied in parallel during 24 h of treatment with 80 µg/mL (~0.5 mM) of the agent. They reported that tryptophol-induced apoptosis involved caspase-8 and -3 activation, followed by cleavage of poly (ADP-ribose) polymerase. In the present study, normal lymphocytes were used as a model system. The results obtained indicate that tryptophol was capable of inducing apoptosis in two higher concentrations (1.00 mM and 2.00 mM) than those used by Inagaki et al. (66) . However, considering that in this study, apoptosis was detected based on morphological changes in the lymphocyte nuclei after staining with fluorescent DNAbinding dyes, further studies are necessary to clarify the exact mechanisms of lymphocyte death following treatment with tryptophol.
CONCLUSIONS
According to the analytical methods used and results presented in this study, it could be concluded that polymorphic C. albicans and C. dubliniensis species produce tryptophol (3-indoleethanol) as a single lowmolecular-weight lipophylic metabolite in vitro. Its production was higher in aerobic conditions, and was detected after an 18h incubation period. In relatively high concentrations, tryptophol caused a cytotoxic effect on cultures of epithelial cells (A549, Hep G-2 and CHO) with an EC 50 between 3 and 7 mM; in culture of fibroblast-like cells (COS-7) with EC 50 6 mM and in culture of monocytes (THP-1) with 2 mM. In sub-cytotoxic concentrations (less than 2 mM), tryptophol caused apoptosis as a primary mode of human lymphocyte death ex situ. As tryptophol induces filamentous form in yeasts, its secretion during candidoses and potential toxic effects on host cells could be expected. Contrary to previously published studies, gliotoxin was not detected in biosynthesis of clinically and commensally isolates of C. albicans and C. dubliniensis strains. The in vivo secretion of tryptophol as a lipophylic low-molecular-weight metabolite, especially during candidosis, should be explored.
